New fm CCII researchers Katsuhiro Ito, Kenji Chamoto , Tomonori Yaguchi et al:
"Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer"
#Immunology #Immunotherapy
@natcomms.nature.com
www.nature.com/articles/s41...
Tumor-reactive T cells (TR-T) in the peripheral blood of cancer patients undergo phenotypic changes during immune checkpoint inhibitor (ICI) therapy, which might predict therapeutic outcomes. Here aut...
